Rangeley Capital »

Adicet Bio shares owned by Rangeley Capital

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $61k 75k 0.81

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding Adicet Bio

OrbiMed Advisors
Tang Capital Management
RA Capital Management
Goldman Sachs Group
Vanguard Group
Carlyle
Acadian Asset Management
Renaissance Technologies
Regeneron Pharmaceuticals
Bridgeway Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management
Alyeska Investment Group
Rbf Capital

View all funds holding Adicet Bio